Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Inc (NASDAQ:THRX)

15.58
BATS BZX Real-Time Price
As of 2:01pm ET
 +1.32 / +9.26%
Today’s Change
10.58
Today|||52-Week Range
23.84
+10.11%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Glaxosmithkline Plc
Buy8/11/2014172,651$22.13$3.8M-35.56%
Glaxosmithkline Plc
Buy3/02/201592,674$19.22$1.8M-25.81%
Glaxosmithkline Plc
Buy5/11/201585,579$16.00$1.4M-11.43%
Lee Junning
Senior Vice President-Technical Operations
Sale8/13/201453,424$22.50$1.2M-36.99%
Shafer Bradford J
General Counsel & Senior Vice President
Sale8/11/201427,108$22.12$599.6K-35.56%
Shafer Bradford J
General Counsel & Senior Vice President
Buy8/11/201433,667$14.53$489.2K-35.56%
Aguiar Michael W
President & Chief Executive Officer
Sale6/02/201524,698$16.68$412.0K-14.51%
Lee Junning
Senior Vice President-Technical Operations
Buy8/13/201424,338$12.66$308.1K-36.99%
Lee Junning
Senior Vice President-Technical Operations
Buy8/13/201423,705$12.66$300.1K-36.99%
Waltrip William H
Director
Sale5/27/201516,313$16.32$266.2K-15.62%
Page of 4